NCT03572101 is a clinical trial in Colorectal Cancer, sponsored by University of Calgary.

Who is sponsoring NCT03572101?

NCT03572101 is sponsored by University of Calgary.

What condition does NCT03572101 study?

NCT03572101 studies Colorectal Cancer.

Is NCT03572101 still recruiting?

NCT03572101 is currently completed. Last updated 30 September 2021.

Last reviewed 2021-09-30 · How we verify

NCT03572101

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Living With Colorectal Cancer: Patient and Caregiver Experience

Completed Last updated 30 September 2021

What this trial tests

trial in Colorectal Cancer in 280 participants. Completed in 31 December 2020.

Timeline

11 January 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	University of Calgary
Status	Completed
Study type	OBSERVATIONAL
Enrollment	280
Start date	11 January 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	3 locations across Canada

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

University of Calgary

Who can join

18 and older, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study will gather outcome and experience data of patients living with advanced colorectal cancer and their caregivers. The primary objective is to measure how quality of life in this population changes over time (before, during, and after a palliative pathway becomes the new standard of care in Calgary, Alberta, Canada).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data.
Watanabe SM, Faily V, Mawani A, Huot A, et al · · 2020 · cited 12× · PMID 32445194 · DOI 10.1634/theoncologist.2019-0384
Colorectal Cancer Patients' Reported Frequency, Content, and Satisfaction with Advance Care Planning Discussions.
Hussein S, Lim CA, Manokaran T, Kassam S, et al · · 2024 · cited 1× · PMID 38534925 · DOI 10.3390/curroncol31030092
Longitudinal Prevalence of Financial Worry in a Cohort of Patients with Advanced Colorectal Cancer: A Secondary Observational Cohort Study.
Douglass-Molloy H, Akude P, Sinnarajah A, Simon J. · · 2025 · PMID 41062079 · DOI 10.1177/10732748251384361

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03572101 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 30 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03572101.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing